Originally Published as The Niche Podcast

Abbott and the FDA develop digital healthcare, Roche gives us some market insight, and we look at Encoded’s approach to gene therapy. 

Sponsors
www.thescopemethod.com

Story References
https://www.roche.com/dam/jcr:5c6df314-831e-4601-9f72-617d28d05e1e/en/23072020_MR_Q2_EN.pdf
https://abbott.mediaroom.com/2020-07-23-Abbott-Receives-FDA-Approval-for-iOS-Compatible-App-Allowing-People-Living-With-Chronic-Pain-and-Movement-Disorders-to-Personalize-Therapy-Via-Their-Mobile-Device
https://encoded.com/encoded-therapeutics-announces-135-million-series-d-financing-to-support-first-clinical-trials-in-scn1a-dravet-syndrome-and-advance-preclinical-pipeline-of-gene-therapies-for-debilitating-neurologic/
 

Music by Luke Goodson
www.soundcloud.com/lukegoodson

Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.